Searched for
OPDYTA
Bristol Myers moves SC to stop Zydus from selling biosimilar cancer drugUS firm Bristol Myers Squibb is in the Supreme Court seeking to halt Zydus Lifesciences from manufacturing and selling a biosimilar cancer ...30 Jan, 2026, 01.44 AM IST- Bristol Myers lines up many launches for India with 'AI' speedBristol Myers Squibb sees India as a major growth driver. The company is investing heavily in AI to speed up drug launches and improve doct...24 Dec, 2025, 09.36 AM IST
- Zydus moves Delhi HC against order restraining manufacture, sale of its cancer drugZydus Lifesciences has appealed a Delhi High Court order. The order restricts it from producing a biosimilar of E.R. Squibb's Nivolumab. Sq...25 Jul, 2025, 12.25 AM IST
- Zydus Life's plans for cancer biosimilar hit a legal hurdleThe Delhi High Court has granted an interim injunction against Zydus Lifesciences, an Ahmedabad-based drug maker, following a patent infrin...21 Jul, 2025, 12.01 AM IST
- Cancer drugmaker Bristol Myers to build its largest R&D facility outside US in India by 2025The $100-million facility, inaugurated by Boerner on Monday, is expected to employ over 1,500 employees and will be used to enhance its dru...27 Feb, 2024, 02.22 PM IST
- World Cancer Day: Immunotherapy can help patients suffering from carcinoma of the lungsImmunotherapy should be given as early as possible to achieve a lasting remission of the disease.04 Feb, 2019, 03.37 PM IST
Load More
